Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GW-876167, a 5-HT2C agonist, is used potentially for the treatment of obesity and glaucoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | GW-876167, a 5-HT2C agonist, is used potentially for the treatment of obesity and glaucoma. |
Synonyms | PRX-00933, PNU-183933, GW876167, BVT933, BVT-933 |
Molecular Weight | 315.37 |
Formula | C16H21N5O2 |
CAS No. | 313658-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GW-876167 313658-33-2 GW 876167 PRX-00933 PNU-183933 GW876167 BVT933 PNU 183933 PNU183933 BVT 933 PRX00933 PRX 00933 BVT-933 inhibitor inhibit